Foresee Pharmaceuticals Co., Ltd.
6576
Rank in Stocks
#14032
Foresee is a Taiwan and US-based biopharmaceutical company focused on two key... Foresee is a Taiwan and US-based biopharmaceutical company focused on two key areas: its unique Stabilized Injectable Formulation (SIF) long-acting injectable technology with derived drug products for specialty markets, and its transformative preclinical and clinical first-in-class New Chemical Entity (NCE) programs targeting rare and severe disease areas with high unmet needs. Its product portfolio includes late and early-stage programs, with its lead product CAMCEVI® used for the treatment of advanced prostate cancer.
Share Price
$2.22
Last synced: 2026-11-10
Market Cap
$349.14M
Change (1 day)
-1.62%
Change (1 year)
-10.09%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Foresee Pharmaceuticals Co., Ltd. (6576)
Category
Healthcare
EPS for Foresee Pharmaceuticals Co., Ltd. (6576)
EPS as of June 2026 TTM: $0.00
According to Foresee Pharmaceuticals Co., Ltd.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of $-0.18, an increase over its 2024 EPS of $-0.24.
EPS history for Foresee Pharmaceuticals Co., Ltd. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -102.39% |
| 2025 | $-0.18 | -24.27% |
| 2024 | $-0.24 | -9.61% |
| 2023 | $-0.27 | 103.30% |
| 2022 | $-0.13 | -24.65% |
| 2021 | $-0.17 | -2.31% |
| 2020 | $-0.18 | 4.42% |
| 2019 | $-0.17 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | 39,202.33% |
US
|
|
| $1.93 | 44,802.33% |
SE
|
|
| $6.91 | 160,690.70% |
FR
|
|
| $0.02 | 353.49% |
HK
|
|
| $2.71 | 62,918.60% |
IT
|
Questions about Foresee Pharmaceuticals Co., Ltd.'s earnings per share (EPS)
What is Foresee Pharmaceuticals Co., Ltd.'s earnings per share (EPS)?
Foresee Pharmaceuticals Co., Ltd.'s earnings per share (EPS) over the last twelve months is $0.00, as of Jun 2026.
What was Foresee Pharmaceuticals Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, Foresee Pharmaceuticals Co., Ltd.'s earnings per share (EPS) was $-0.18, compared with $-0.24 in 2024.
How has Foresee Pharmaceuticals Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Foresee Pharmaceuticals Co., Ltd.'s earnings per share (EPS) was highest in 2022 ($-0.13) and lowest in 2023 ($-0.27).
How does Foresee Pharmaceuticals Co., Ltd.'s earnings per share (EPS) compare with similar companies?
Foresee Pharmaceuticals Co., Ltd.'s earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.